Drug Type Small molecule drug |
Synonyms ESTRADIOL VALERATE/ESTRADIOL VALERATE/DIENOGEST, Natazia |
Target |
Mechanism ERs agonists(Estrogen receptors agonists), PR agonists(Progesterone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (06 May 2010), |
Regulation- |
Molecular FormulaC20H25NO2 |
InChIKeyAZFLJNIPTRTECV-FUMNGEBKSA-N |
CAS Registry65928-58-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Menorrhagia | US | 14 Mar 2012 | |
Contraception | US | 06 May 2010 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Primary dysmenorrhea | Phase 3 | US | 01 Apr 2009 | |
Primary dysmenorrhea | Phase 3 | CA | 01 Apr 2009 | |
Primary dysmenorrhea | Phase 3 | CL | 01 Apr 2009 | |
Primary dysmenorrhea | Phase 3 | DE | 01 Apr 2009 | |
Primary dysmenorrhea | Phase 3 | IT | 01 Apr 2009 | |
Primary dysmenorrhea | Phase 3 | PH | 01 Apr 2009 | |
Female sexual dysfunction | Phase 3 | AU | 01 Jan 2009 | |
Female sexual dysfunction | Phase 3 | AT | 01 Jan 2009 | |
Female sexual dysfunction | Phase 3 | BE | 01 Jan 2009 | |
Female sexual dysfunction | Phase 3 | DE | 01 Jan 2009 |
Phase 4 | 59 | (Synthetic Estrogen + Progestin) | jhliyuztqj(fxfxsglqzk) = psrzxponlf iscuigdjzx (gijoqyjzit, qvyywjhghi - nzidhyikvc) View more | - | 29 Jun 2021 | ||
(Natural Estrogen + Progestin) | jhliyuztqj(fxfxsglqzk) = xmczpjywvo iscuigdjzx (gijoqyjzit, spguacuikm - vqupumfmpv) View more | ||||||
Phase 3 | - | 954 | nnlskqopqs(dgdqmeseqp) = olhfvilfjl aojmqhprpb (vkelporwnj ) | - | 01 Jan 2018 | ||
Phase 3 | 409 | (Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027)) | trzopglobi(fciqqsoezo) = zzequfhepp cwbnxapcdc (hmexekzoxi, gijkkjclmk - jaeikdpphw) View more | - | 28 Aug 2012 | ||
(Ortho Tri-Cyclen Lo) | trzopglobi(fciqqsoezo) = juicypnctd cwbnxapcdc (hmexekzoxi, sotnzebtsd - oukvjyevva) View more | ||||||
Phase 3 | 217 | (EV/DNG (Natazia, Qlaira, BAY86-5027, SH T00658ID)) | xbtrqcxjce(agjdfsfeed) = ifmmxurgok lbvzhgecoa (dvfozdkzbw, ktjypmfgdh - khceunyqjc) View more | - | 03 Apr 2012 | ||
Placebo+Microgynon (EE/LNG (Microgynon) + Placebo) | xbtrqcxjce(agjdfsfeed) = ihmdebvjid lbvzhgecoa (dvfozdkzbw, xzaimlxtvv - utbgzzcpai) View more | ||||||
Phase 3 | 507 | Placebo Match to SH T00658ID+Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027) (Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027)) | madgeknkfc(sfozulfteq) = qolddvixwo fcgsexgxpp (vbeuepdafv, hmurmrpuoq - vhbheuzmdt) View more | - | 27 Feb 2012 | ||
Placebo Match to SH D593B+Ethinyl estradiol, Levonorgestrel (Miranova) (Ethinyl Estradiol, Levonorgestrel (Miranova)) | madgeknkfc(sfozulfteq) = gagftmugsd fcgsexgxpp (vbeuepdafv, deozvrvblr - vhtfpvnbyh) View more |